PubMed · 1991 · 29 citations · 14 references
MedicineOncologyPathologyHematologic OncologyMonoclonal AntibodiesNeoplasiaHematologic MalignanciesLymphoid NeoplasmsLymphoid Tissue PathologyLymphoid TumorsMalignant NeoplasmsTumor AntigensLymphoma BiomarkersLymphoma PathogenesisSystematic Literature Review
The monoclonal antibody HMB-45 is a highly specific and sensitive marker of malignant melanoma. Rarely, however, aberrant reactivity to nonmelanocytic tumors has been observed. We report an immunoblastic lymphoma of B-cell phenotype that reacted with HMB-45 in a 70-year-old white woman. To our knowledge, this is the first report of HMB-45-positive malignant lymphoma (excluding plasmacytoma). Of an additional 13 cases of benign and malignant lymphoid tissue, only benign plasma cells in one case reacted with HMB-45.
14
GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells
Christophe Caux, Colette Dezutter‐Dambuyant, Daniel Schmitt et al. · Nature · 1992 · 1.6K citations
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Alex Y. Huang, Paul T. Golumbek, Mojgan Ahmadzadeh et al. · Science · 1994 · 1.2K citations
Life Sciences, Immunology, Oncology +17
Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4
Paul T. Golumbek, Audrey J. Lazenby, Hyam I. Levitsky et al. · Science · 1991 · 731 citations
Medicine, Immunology, Oncology +17